*Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, Warren Alpert Medical School of Brown University, Providence, RI;
†Department of Dermatology, Rhode Island Hospital and Lifespan Medical Center, Warren Alpert Medical School of Brown University, Providence, RI;
‡Division of Hematology Oncology, Rhode Island Hospital and Lifespan Cancer Center, Warren Alpert Medical School of Brown University, Providence, RI;
§Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
¶Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland; and
‖Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Correspondence: Diana O. Treaba, MD, Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, 593 Eddy Street, Providence, RI 02903 (e-mail: [email protected]).
The authors declare no conflicts of interest.
The abstract of this study was presented at the 56th American Society of Dermatopathology Annual Meeting; October 19, 2019.
